123 related articles for article (PubMed ID: 29499505)
1. Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder.
Tomioka Y; Jiménez E; Salagre E; Arias B; Mitjans M; Ruiz V; Sáiz P; García-Portilla MP; de la Fuente L; Gomes-da-Costa SP; Bobes J; Vieta E; Benabarre A; Grande I
J Affect Disord; 2018 May; 232():229-236. PubMed ID: 29499505
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients.
Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Oquendo MA; Vieta E; Benabarre A
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1452-62. PubMed ID: 23453640
[TBL] [Abstract][Full Text] [Related]
3. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
Bloch PJ; Weller AE; Doyle GA; Ferraro TN; Berrettini WH; Hodge R; Lohoff FW
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1515-9. PubMed ID: 20800640
[TBL] [Abstract][Full Text] [Related]
4. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Sjøholt G; Ebstein RP; Lie RT; Berle JØ; Mallet J; Deleuze JF; Levinson DF; Laurent C; Mujahed M; Bannoura I; Murad I; Molven A; Steen VM
Mol Psychiatry; 2004 Jun; 9(6):621-9. PubMed ID: 14699425
[TBL] [Abstract][Full Text] [Related]
5. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
Dimitrova A; Milanova V; Krastev S; Nikolov I; Toncheva D; Owen MJ; Kirov G
Pharmacogenomics J; 2005; 5(1):35-41. PubMed ID: 15505643
[TBL] [Abstract][Full Text] [Related]
6. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
Ohnishi T; Yamada K; Ohba H; Iwayama Y; Toyota T; Hattori E; Inada T; Kunugi H; Tatsumi M; Ozaki N; Iwata N; Sakamoto K; Iijima Y; Iwata Y; Tsuchiya KJ; Sugihara G; Nanko S; Osumi N; Detera-Wadleigh SD; Kato T; Yoshikawa T
Neuropsychopharmacology; 2007 Aug; 32(8):1727-37. PubMed ID: 17251911
[TBL] [Abstract][Full Text] [Related]
7. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).
Yoshikawa T; Padigaru M; Karkera JD; Sharma M; Berrettini WH; Esterling LE; Detera-Wadleigh SD
Mol Psychiatry; 2000 Mar; 5(2):165-71. PubMed ID: 10822344
[TBL] [Abstract][Full Text] [Related]
8. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder.
Yoon IS; Li PP; Siu KP; Kennedy JL; Cooke RG; Parikh SV; Warsh JJ
Mol Psychiatry; 2001 Nov; 6(6):678-83. PubMed ID: 11673796
[TBL] [Abstract][Full Text] [Related]
9. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.
Sjøholt G; Gulbrandsen AK; Løvlie R; Berle JO; Molven A; Steen VM
Mol Psychiatry; 2000 Mar; 5(2):172-80. PubMed ID: 10822345
[TBL] [Abstract][Full Text] [Related]
10. Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2.
Ohnishi T; Watanabe A; Ohba H; Iwayama Y; Maekawa M; Yoshikawa T
Neurosci Res; 2010 May; 67(1):86-94. PubMed ID: 20153384
[TBL] [Abstract][Full Text] [Related]
11. Association between toll-like receptor 2 gene diversity and early-onset bipolar disorder.
Oliveira J; Hamdani N; Busson M; Etain B; Bennabi M; Amokrane K; Boukouaci W; Fortier C; Marzais F; Bengoufa D; Bellivier F; Henry C; Kahn JP; Charron D; Krishnamoorthy R; Le Corvoisier P; Leboyer M; Tamouza R
J Affect Disord; 2014 Aug; 165():135-41. PubMed ID: 24882191
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures.
Arai R; Ito K; Ohnishi T; Ohba H; Akasaka R; Bessho Y; Hanawa-Suetsugu K; Yoshikawa T; Shirouzu M; Yokoyama S
Proteins; 2007 May; 67(3):732-42. PubMed ID: 17340635
[TBL] [Abstract][Full Text] [Related]
13. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive functioning in early-onset and late-onset older patients with euthymic bipolar disorder.
Martino DJ; Strejilevich SA; Manes F
Int J Geriatr Psychiatry; 2013 Feb; 28(2):142-8. PubMed ID: 22451354
[TBL] [Abstract][Full Text] [Related]
15. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.
Ohnishi T; Ohba H; Seo KC; Im J; Sato Y; Iwayama Y; Furuichi T; Chung SK; Yoshikawa T
J Biol Chem; 2007 Jan; 282(1):637-46. PubMed ID: 17068342
[TBL] [Abstract][Full Text] [Related]
16. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.
Yoshikawa T; Kikuchi M; Saito K; Watanabe A; Yamada K; Shibuya H; Nankai M; Kurumaji A; Hattori E; Ishiguro H; Shimizu H; Okubo Y; Toru M; Detera-Wadleigh SD
Mol Psychiatry; 2001 Mar; 6(2):202-10. PubMed ID: 11317223
[TBL] [Abstract][Full Text] [Related]
17. Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.
Nakayama J; Yamamoto N; Hamano K; Iwasaki N; Ohta M; Nakahara S; Matsui A; Noguchi E; Arinami T
Neurology; 2004 Nov; 63(10):1803-7. PubMed ID: 15557493
[TBL] [Abstract][Full Text] [Related]
18. Early-onset and very-early-onset bipolar disorder: distinct or similar clinical conditions?
Propper L; Ortiz A; Slaney C; Garnham J; Ruzickova M; Calkin CV; O'Donovan C; Hajek T; Alda M
Bipolar Disord; 2015 Dec; 17(8):814-20. PubMed ID: 26576693
[TBL] [Abstract][Full Text] [Related]
19. Increased rates of white matter hyperintensities in late-onset bipolar disorder.
Tamashiro JH; Zung S; Zanetti MV; de Castro CC; Vallada H; Busatto GF; de Toledo Ferraz Alves TC
Bipolar Disord; 2008 Nov; 10(7):765-75. PubMed ID: 19032708
[TBL] [Abstract][Full Text] [Related]
20. Classifying mood disorders by age-at-onset instead of polarity.
Benazzi F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
